SCHOTT, Daikyo and Vanrx for pharmaceutical primary packaging
SCHOTT adaptiQ vials, Daikyo Seiko PLASCAP press-fit closures and Vanrx Aseptic Filling Workcells combine for a primary packaging system for pharmaceuticals

SCHOTT AG, Daikyo Seiko and Vanrx announce compatibility for vials, press-fit closures and aseptic filling machines for sterile injectable drug packaging

April 9, 2018 - Featured, Matrix Alliance

VANCOUVER, CANADA – SCHOTT AG and Daikyo Seiko Ltd. are announcing that SCHOTT adaptiQ® vials and Daikyo PLASCAP® plastic press-fit closures are confirmed as a Product Set for use with Vanrx Pharmasystems’ Aseptic Filling Workcells.

As of this date, this Product Set of 2R and 4R vials with 13mm press-fit closures is fully commercially available and ready-to-use (RTU), with closure integrity performance results available from the suppliers. These products are certified to work with Vanrx’s Microcell Vial Filler and SA25 Aseptic Filling Workcell.

The compatibility testing was part of the Matrix Alliance—an industry initiative of leading packaging and component suppliers, which aims at providing pre-validated container / closure solutions to work on Vanrx’s Aseptic Filling Workcells.

Speaking on behalf of the three companies, Vanrx’s vice president of marketing Greg Speakman said:

“SCHOTT, Daikyo and Vanrx have tested the compatibility of this combination extensively to ensure that pharmaceutical companies can bring new drug products to market faster. With so many variables to solve on the way to launch, we think it’s helpful to provide our customers with combined solutions in which they can be confident.”

Using this Product Set, pharmaceutical companies have the assurance that the combination will function as a high-performance primary packaging system for sterile injectables. Companies can move drug products to market faster, by establishing flexible manufacturing operations using pre-sterilized, nested ready-to-use vials and press-fit closures with integrated stoppers in combination with Vanrx’s robotic aseptic filling systems.

The testing leading to this product set was completed as part of the Matrix Alliance, a collaboration between leading pharmaceutical packaging companies, of which Vanrx, SCHOTT, and Daikyo Seiko are members. The Alliance was created because next-generation drugs require highly aligned manufacturing processes and packaging solutions.

Media & Product Information Contacts

For SCHOTT adaptiQ® vials:

Gregor Deutschle
Director, Business Development Sterile Solutions
SCHOTT AG
E-mail: gregor.deutschle@schott.com
Phone: +49 151 14803464

Media contact:
Christina Rettig
E-mail: christina.rettig@schott.com
Phone: +49 151 54374595

For PLASCAP® plastic press-fit closures:
Ryoichi Hayashi
Product Manager
Daikyo Seiko Ltd.
E-mail: ryoichi-hayashi@daikyoseiko.jp
Phone: +81 -3-4400-7921

For Vanrx Aseptic Filling Workcells:
Eric Petz
Senior Marketing Manager
Vanrx Pharmasystems
E-mail: epetz@vanrx.com
Phone: +1.778.228.4177

About SCHOTT AG

SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. The group maintains a global presence with production sites and sales offices in 33 countries. With its workforce of approximately 15,000 employees, sales of 2.05 billion euros were generated in fiscal year 2016/2017. The parent company, SCHOTT AG, has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment. For more information, please visit the SCHOTT web site.

About Daikyo Seiko Ltd.

Daikyo Seiko, Ltd. is a leading manufacturer of high-quality injectable packaging components that include: Daikyo Flurotec® film laminated elastomeric closures, Crystal Zenith® cyclic olefin polymer containment and delivery systems, PLASCAP® seals, and various medical device components. Targeting a “Zero defect” quality, Daikyo products are manufactured in clean rooms and released under 100% vision inspection. Daikyo offers components as sterile and ready to sterilize; and also offers customization. Headquartered in Tochigi, Japan—with manufacturing plants are in Sano, Tochigi Prefecture—Daikyo works closely with pharmaceutical customers to innovate and continuously improve manufacturing processes. Since the late 1970s, Daikyo and West Pharmaceutical Services, Inc. have partnered to provide the pharmaceutical industry with a comprehensive portfolio of products for injectable drugs and healthcare products. For more information, please visit www.daikyoseiko.jp/english/index.html.

About Vanrx Pharmasystems

Vanrx Pharmasystems makes the most technologically advanced sterile filling solutions for the pharmaceutical industry. Vanrx fill-finish machines use isolated robotics and machine vision to automate the packaging of injectable drugs into nested vials, syringes, or cartridges. The company was founded by pharmaceutical industry veterans to create the systems needed to make the next generation of innovative therapies. For more information, visit www.vanrx.com.

Trademarks
adaptiQ® is a registered trademark of SCHOTT AG.
PLASCAP® is a registered trademark of Daikyo Seiko.